|
ATE182148T1
(de)
|
1995-05-12 |
1999-07-15 |
Neurogen Corp |
Neue deazapurinderivate; eine neue klasse von crf1-spezifischen liganden
|
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
|
JP2001511813A
(ja)
*
|
1997-02-18 |
2001-08-14 |
ニューロクライン バイオサイエンシーズ，インコーポレイテッド |
Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
|
|
JP2002501493A
(ja)
|
1997-04-22 |
2002-01-15 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｃｒｆアンタゴニストのチオフェノピリジン類
|
|
CA2294117A1
(en)
*
|
1997-07-03 |
1999-01-14 |
Dupont Pharmaceuticals Company |
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
|
|
CA2614603C
(en)
*
|
1998-01-28 |
2011-08-16 |
Bristol-Myers Squibb Pharma Company |
Azolo triazines and pyrimidines
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
WO1999051597A1
(en)
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
|
|
US6472402B1
(en)
|
1998-04-02 |
2002-10-29 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
|
|
WO1999051608A1
(en)
*
|
1998-04-03 |
1999-10-14 |
Du Pont Pharmaceuticals Company |
THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
|
|
CA2334671A1
(en)
|
1998-06-09 |
1999-12-16 |
Neurogen Corporation |
Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
AU5777299A
(en)
*
|
1998-08-21 |
2000-03-14 |
Du Pont Pharmaceuticals Company |
Isoxazolo(4,5-d)pyrimidines as CRF antagonists
|
|
JP2002529469A
(ja)
|
1998-11-12 |
2002-09-10 |
ニューロクライン バイオサイエンシーズ， インコーポレイテッド |
Ｃｒｆレセプターアンタゴニストおよびそれに関する方法
|
|
WO2000027846A2
(en)
|
1998-11-12 |
2000-05-18 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists and methods relating thereto
|
|
US6531475B1
(en)
*
|
1998-11-12 |
2003-03-11 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
|
AU2321000A
(en)
*
|
1999-01-29 |
2000-08-18 |
Sumitomo Chemical Company, Limited |
Fat accumulation inhibitory agents
|
|
EP1040831A3
(en)
*
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
WO2000059907A2
(en)
|
1999-04-06 |
2000-10-12 |
Du Pont Pharmaceuticals Company |
Pyrazolotriazines as crf antagonists
|
|
WO2000059908A2
(en)
*
|
1999-04-06 |
2000-10-12 |
Du Pont Pharmaceuticals Company |
Pyrazolopyrimidines as crf antagonists
|
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
EP1669071B1
(en)
*
|
1999-05-21 |
2009-07-22 |
Bristol-Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
US6432989B1
(en)
*
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
PL354675A1
(en)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
SE9903544D0
(sv)
|
1999-10-01 |
1999-10-01 |
Astra Pharma Prod |
Novel compounds
|
|
CO5271670A1
(es)
|
1999-10-29 |
2003-04-30 |
Pfizer Prod Inc |
Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
|
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
|
DE60101372T2
(de)
*
|
2000-02-11 |
2004-10-14 |
Astrazeneca Ab |
Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
|
|
GB2359081A
(en)
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active thiazolopyrimidines
|
|
GB2359078A
(en)
*
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
|
AU2001232271A1
(en)
*
|
2000-02-14 |
2001-08-20 |
Japan Tobacco Inc. |
Preventives/remedies for postoperative stress
|
|
GB2359551A
(en)
|
2000-02-23 |
2001-08-29 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
|
EP1149583A3
(en)
*
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
|
|
JP2003533530A
(ja)
*
|
2000-05-18 |
2003-11-11 |
ニューロクライン バイオサイエンシーズ， インコーポレイテッド |
Ｃｒｆレセプターアンタゴニスト
|
|
EP1294718A2
(en)
|
2000-06-14 |
2003-03-26 |
Warner-Lambert Company Llc |
6,5-fused bicyclic heterocycles
|
|
US6630476B2
(en)
*
|
2000-07-07 |
2003-10-07 |
Bristol-Myers Squibb Pharma Company |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
|
|
SE0003828D0
(sv)
|
2000-10-20 |
2000-10-20 |
Astrazeneca Ab |
Novel compounds
|
|
US6867300B2
(en)
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
|
JP3528968B2
(ja)
|
2000-12-28 |
2004-05-24 |
小野薬品工業株式会社 |
三環式複素環誘導体化合物およびその化合物を有効成分とする医薬
|
|
GB0100624D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VII
|
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
DE60218434T2
(de)
*
|
2001-03-13 |
2007-11-08 |
Bristol-Myers Squibb Pharma Co. |
4-(2-BUTYLAMINO)-2,7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-YL) PYRAZOLO- 1,5-Aö-1,3,5-TRIAZIN, SEINE ENANTIOMEREN UND PHARMAZEUTISCH ANNEHMBARE SALZE ALS CORTICOTROPIN-RELEASING-FACTOR-REZEPTOR-LIGANDEN
|
|
SE0101322D0
(sv)
|
2001-04-12 |
2001-04-12 |
Astrazeneca Ab |
Novel compounds
|
|
RU2308457C2
(ru)
*
|
2001-04-27 |
2007-10-20 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Пиразоло [1, 5-а] пиридины и содержащие их лекарственные средства
|
|
NZ529471A
(en)
*
|
2001-05-21 |
2005-12-23 |
Neurocrine Inc |
Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
|
|
GB0117396D0
(en)
*
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
TW200300350A
(en)
|
2001-11-14 |
2003-06-01 |
Bristol Myers Squibb Co |
C-5 modified indazolylpyrrolotriazines
|
|
JP2005525382A
(ja)
|
2002-03-07 |
2005-08-25 |
スミスクライン ビーチャム コーポレーション |
ピラゾロピリミジンおよびピラゾロトリアジン誘導体ならびにそれを含む医薬組成物
|
|
EP1348707B1
(en)
*
|
2002-03-28 |
2010-08-25 |
Ustav Experimentalni Botaniky AV CR, v.v.i. (Institute of Experimental Botany Academy of Sciences of the Czech Republic, PRO) |
Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
|
|
US7119200B2
(en)
*
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
GB0221828D0
(en)
|
2002-09-20 |
2002-10-30 |
Astrazeneca Ab |
Novel compound
|
|
AR041470A1
(es)
*
|
2002-10-17 |
2005-05-18 |
Upjohn Co |
Compuestos de pirrolo (1,2 - b) piridazina y sus usos
|
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
|
JP4322211B2
(ja)
|
2002-10-22 |
2009-08-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
７−フェニルピラゾロピリジン化合物
|
|
TW200420565A
(en)
|
2002-12-13 |
2004-10-16 |
Bristol Myers Squibb Co |
C-6 modified indazolylpyrrolotriazines
|
|
EP1599468B1
(en)
|
2003-01-14 |
2007-10-03 |
Arena Pharmaceuticals, Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
|
NZ541836A
(en)
*
|
2003-02-27 |
2008-12-24 |
Palau Pharma Sa |
Pyrazolopyridine derivatives
|
|
US7041671B2
(en)
|
2003-04-02 |
2006-05-09 |
Pfizer Inc |
Pyrrolo[1,2-b]pyridazine compounds and their uses
|
|
US7056920B2
(en)
*
|
2003-04-04 |
2006-06-06 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
US7034023B2
(en)
|
2003-04-04 |
2006-04-25 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2520805A1
(en)
*
|
2003-04-15 |
2004-10-28 |
Pharmacia & Upjohn Company Llc |
Pyrrolo[1,2-b]pyridazine compounds and their uses
|
|
CA2523831C
(en)
|
2003-04-29 |
2008-11-18 |
Pfizer Inc. |
5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
|
|
WO2004099213A2
(en)
*
|
2003-05-07 |
2004-11-18 |
Pharmacia & Upjohn Company Llc |
Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
|
|
WO2004110454A1
(ja)
*
|
2003-06-13 |
2004-12-23 |
Ishihara Sangyo Kaisha, Ltd. |
アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
AR045697A1
(es)
|
2003-07-14 |
2005-11-09 |
Arena Pharm Inc |
Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
|
|
AU2004270713A1
(en)
*
|
2003-09-05 |
2005-03-17 |
Aventis Pharmaceuticals Inc. |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
|
|
US7153961B2
(en)
|
2003-11-25 |
2006-12-26 |
Bristol-Myers Squibb Pharma Co. |
Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
|
|
US7208596B2
(en)
|
2003-11-25 |
2007-04-24 |
Bristol-Myers Squibb Pharma Company |
Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
|
|
GB0328243D0
(en)
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Methods
|
|
US7102001B2
(en)
|
2003-12-12 |
2006-09-05 |
Bristol-Myers Squibb Company |
Process for preparing pyrrolotriazine
|
|
RU2394035C2
(ru)
|
2003-12-22 |
2010-07-10 |
Эс Би ФАРМКО ПУЭРТО РИКО ИНК. |
Антагонисты crf-рецепторов и способы, относящиеся к ним
|
|
US7064203B2
(en)
|
2003-12-29 |
2006-06-20 |
Bristol Myers Squibb Company |
Di-substituted pyrrolotriazine compounds
|
|
MY145634A
(en)
|
2003-12-29 |
2012-03-15 |
Bristol Myers Squibb Co |
Pyrrolotriazine compounds as kinase inhibitors
|
|
RU2367663C2
(ru)
*
|
2004-01-06 |
2009-09-20 |
Тайсо Фармасьютикал Ко., Лтд. |
Производные пирролопиримидина и пирролотриазина
|
|
CN1910190A
(zh)
|
2004-01-06 |
2007-02-07 |
大正制药株式会社 |
环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物
|
|
PL1718608T3
(pl)
|
2004-02-20 |
2013-11-29 |
Boehringer Ingelheim Int |
Inhibitory polimerazy wirusowej
|
|
US7102002B2
(en)
|
2004-06-16 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US7102003B2
(en)
|
2004-07-01 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine compounds
|
|
US7504521B2
(en)
|
2004-08-05 |
2009-03-17 |
Bristol-Myers Squibb Co. |
Methods for the preparation of pyrrolotriazine compounds
|
|
PE20060421A1
(es)
|
2004-08-12 |
2006-06-01 |
Bristol Myers Squibb Co |
Procedimiento para preparar un compuesto de pirrolotriazina anilina como inhibidores de cinasa
|
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
|
ES2326827T3
(es)
*
|
2004-10-19 |
2009-10-20 |
Smithkline Beecham (Cork) Limited |
Anatagonistas del receptor de crf y metodos relacionados.
|
|
US7151176B2
(en)
|
2004-10-21 |
2006-12-19 |
Bristol-Myers Squibb Company |
Pyrrolotriazine compounds
|
|
AU2005302448B2
(en)
|
2004-10-29 |
2012-07-19 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
|
US7674822B2
(en)
|
2004-11-24 |
2010-03-09 |
Wyeth |
PTP1b inhibitors
|
|
EP2537520A1
(en)
|
2005-03-29 |
2012-12-26 |
Biocryst Pharmaceuticals, Inc. |
Hepatics C therapies
|
|
US20090234117A1
(en)
*
|
2005-05-27 |
2009-09-17 |
Toshihiko Kashiwagi |
Pyrazolopyrimidine Derivative
|
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
|
WO2007013964A1
(en)
|
2005-07-22 |
2007-02-01 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
US7514435B2
(en)
|
2005-11-18 |
2009-04-07 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US8063208B2
(en)
|
2006-02-16 |
2011-11-22 |
Bristol-Myers Squibb Company |
Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
|
|
ES2350282T3
(es)
|
2006-09-20 |
2011-01-20 |
Eli Lilly And Company |
Tiazol pirazolopirimidinas como antagonistas del receptor de crf1.
|
|
KR101088196B1
(ko)
|
2006-09-20 |
2011-11-30 |
일라이 릴리 앤드 캄파니 |
티오펜 피라졸로피리미딘 화합물
|
|
KR20140104060A
(ko)
|
2006-10-19 |
2014-08-27 |
시그날 파마소티칼 엘엘씨 |
헤테로아릴 화합물, 이들의 조성물 그리고 단백질 키나아제 억제제로서의 이들의 용도
|
|
NZ586662A
(en)
|
2007-12-19 |
2012-08-31 |
Vertex Pharma |
PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS
|
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
|
NZ588376A
(en)
|
2008-04-15 |
2011-06-30 |
Eisai R&D Man Co Ltd |
3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor
|
|
GB0906579D0
(en)
|
2009-04-16 |
2009-05-20 |
Vernalis R&D Ltd |
Pharmaceuticals, compositions and methods of making and using the same
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
|
CN102947302A
(zh)
*
|
2010-02-18 |
2013-02-27 |
西班牙国家癌症研究中心 |
三唑并[4，5-b]吡啶衍生物
|
|
US8912184B1
(en)
|
2010-03-01 |
2014-12-16 |
Alzheimer's Institute Of America, Inc. |
Therapeutic and diagnostic methods
|
|
CN102933584A
(zh)
*
|
2010-04-16 |
2013-02-13 |
Abbvie公司 |
激酶的吡咯并吡嗪酮抑制剂
|
|
WO2011137155A1
(en)
|
2010-04-28 |
2011-11-03 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
|
AU2011305525B2
(en)
|
2010-09-22 |
2016-08-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
|
US9266880B2
(en)
|
2010-11-12 |
2016-02-23 |
Bristol-Myers Squibb Company |
Substituted azaindazole compounds
|
|
CA2821837A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Intellectual Property Gmbh |
2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
WO2012080234A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Pharma Aktiengesellschaft |
Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
WO2012080229A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Pharma Aktiengesellschaft |
Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders
|
|
PH12013502033A1
(en)
|
2011-04-08 |
2014-01-06 |
Janssen Sciences Ireland Uc |
Pyrimidine derivatives for the treatment of viral infections
|
|
WO2012149157A2
(en)
*
|
2011-04-26 |
2012-11-01 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
US8969586B2
(en)
|
2011-09-27 |
2015-03-03 |
Bristol-Myers Squibb Company |
Substituted bicyclic heteroaryl compounds
|
|
EP2776439B1
(en)
|
2011-11-09 |
2018-07-04 |
Janssen Sciences Ireland UC |
Purine derivatives for the treatment of viral infections
|
|
US9512126B2
(en)
|
2012-03-14 |
2016-12-06 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
|
MX362197B
(es)
*
|
2012-07-09 |
2019-01-08 |
Janssen Pharmaceutica Nv |
Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos.
|
|
WO2014009509A1
(en)
|
2012-07-13 |
2014-01-16 |
Janssen R&D Ireland |
Macrocyclic purines for the treatment of viral infections
|
|
WO2014020041A1
(en)
|
2012-08-02 |
2014-02-06 |
Bayer Pharma Aktiengesellschaft |
Combinations for the treatment of cancer
|
|
US9499549B2
(en)
|
2012-10-10 |
2016-11-22 |
Janssen Sciences Ireland Uc |
Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases
|
|
US10392389B2
(en)
|
2012-10-25 |
2019-08-27 |
Bioenergenix Llc |
Heterocyclic compounds for the inhibition of PASK
|
|
US9278973B2
(en)
|
2012-10-25 |
2016-03-08 |
Bioenergenix Llc |
Heterocyclic compounds for the inhibition of PASK
|
|
UA118341C2
(uk)
|
2012-11-16 |
2019-01-10 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Гетероциклічні заміщені похідні 2-амінохіназоліну для лікування вірусних інфекцій
|
|
UA118751C2
(uk)
|
2013-02-21 |
2019-03-11 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Похідні 2-амінопіримідину для лікування вірусних інфекцій
|
|
US10035801B2
(en)
|
2013-03-13 |
2018-07-31 |
Genentech, Inc. |
Pyrazolo compounds and uses thereof
|
|
BR112015024411B1
(pt)
|
2013-03-29 |
2022-02-22 |
Janssen Sciences Ireland Uc |
Desaza-purinonas macrocíclicas para o tratamento de infeções virais e composição farmacêutica que os compreende
|
|
AU2014270418B2
(en)
|
2013-05-24 |
2017-11-30 |
Janssen Sciences Ireland Uc |
Pyridone derivatives for the treatment of viral infections and further diseases
|
|
AP2015008898A0
(en)
|
2013-06-11 |
2015-12-31 |
Bayer Pharma AG |
Prodrug derivatives of substituted triazolopyridines
|
|
NO3030563T3
(enExample)
*
|
2013-06-27 |
2018-01-06 |
|
|
|
CA2913691C
(en)
|
2013-07-30 |
2022-01-25 |
Janssen Sciences Ireland Uc |
Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
|
|
EP2940022B1
(en)
|
2014-04-30 |
2020-09-02 |
Masarykova Univerzita |
Furopyridines as inhibitors of protein kinases
|
|
CN116850181A
(zh)
|
2015-01-06 |
2023-10-10 |
艾尼纳制药公司 |
治疗与s1p1受体有关的病症的方法
|
|
AU2016284162A1
(en)
|
2015-06-22 |
2018-02-01 |
Arena Pharmaceuticals, Inc. |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(Compound1) for use in SIP1 receptor-associated disorders
|
|
RU2699568C2
(ru)
*
|
2015-12-21 |
2019-09-06 |
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" |
Лиганды транслокаторного белка TSPO, обладающие антидепрессивной и ноотропной активностью
|
|
CN109476675B
(zh)
|
2016-07-01 |
2022-12-09 |
爱尔兰詹森科学公司 |
用于治疗病毒性感染的二氢吡喃并嘧啶衍生物
|
|
AU2017335205B2
(en)
|
2016-09-29 |
2021-11-04 |
Janssen Sciences Ireland Unlimited Company |
Pyrimidine prodrugs for the treatment of viral infections and further diseases
|
|
KR20250022913A
(ko)
|
2017-08-14 |
2025-02-17 |
스프루스 바이오사이언시스 인코포레이티드 |
코티코트로핀 방출 인자 수용체 길항제
|
|
TW202415645A
(zh)
|
2018-03-01 |
2024-04-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
２，４－二胺基喹唑啉衍生物及其醫學用途
|
|
WO2019236757A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
CN108812546A
(zh)
*
|
2018-09-07 |
2018-11-16 |
四川省草原科学研究院 |
适于青藏高原地区牦牛运输减少应激的药物及使用方法
|
|
AU2021324839B2
(en)
|
2020-08-12 |
2024-02-29 |
Spruce Biosciences, Inc. |
Methods and compositions for treating polycystic ovary syndrome
|
|
US11708372B2
(en)
|
2021-11-19 |
2023-07-25 |
Spruce Biosciences, Inc. |
Crystalline composition of tildacerfont and methods of use and preparation thereof
|